| Symbol | EVGN |
|---|---|
| Name | EVOGENE LTD |
| Sector | INDUSTRIALS |
| Region | Middle East |
| Industry | BIOMED |
| Address | 13 GAD FEINSTEIN STREET,PARK REHOVOT, P.O. BOX 4173, REHOVOT, 7414002, Israel |
| Telephone | 08-9311900 |
| Fax | 08-9466724 |
| ofer.haviv@evogene.com | |
| Website | www.evogene.com |
| Incorporation | Israel |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | TASE;NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001574565 |
| Description | Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment. Additional info from NASDAQ: |
New Form EFFECT - Evogene Ltd. <b>Filed:</b> 2026-04-15 <b>AccNo:</b> 9999999995-26-001196 <b>Size:</b> 1 KB
Read moreNew Form 3 - Evogene Ltd. <b>Filed:</b> 2026-04-09 <b>AccNo:</b> 0001178913-26-002034 <b>Size:</b> 15 KB
Read moreNASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.
Read moreNASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.
Read moreNew Form EFFECT - Evogene Ltd. <b>Filed:</b> 2026-04-03 <b>AccNo:</b> 9999999995-26-001076 <b>Size:</b> 1 KB
Read more